Methods for blood group antigens detection: cost-effectiveness analysis of phenotyping and genotyping

被引:11
作者
Quirino, Marilia Goncalves [1 ]
Colli, Cristiane Maria [1 ]
Macedo, Luciana Conci [1 ]
Sell, Ana Maria [1 ]
Laguila Visentainer, Jeane Eliete [1 ]
机构
[1] Univ Estadual Maringa UEM, Maringa, Parana, Brazil
关键词
Cost analysis; Molecular biology; Serology; Blood group antigens; TRANSFUSION; DNA;
D O I
10.1016/j.htct.2018.06.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Alloimmunization is a major problem in transfusion practice due to the clinical complications of the patients and the difficulty of choosing a unit of compatible blood product. Serological methods are widely used in blood banks, but they not always determine the phenotype. Thus, genotyping is an important complement to the serology tool as it allows one to predict the phenotype from deoxyribonucleic acid (DNA) with high accuracy. Objective: To compare the centrifugation gel, microarray, Restriction Fragment Length Polymorphismone PCR (PCR-RFLP) and Sequence-Specific Primer PCR (PCR-SSP) techniques, in terms of cost, reaction time and reliability of the results. Methods: The RHCE, Kidd, Kell and Duffy blood group systems were chosen to determine the approximate cost of each technique, considering the reagents used in both methods and considering only one sample. The time required for the development of each reaction was obtained at the Maringa Regional Blood Center and Immunogenetics Laboratory at the State University of Maringa. Data from Microarray reactions were obtained at the Campinas Blood Center. The results of phenotyping and genotyping of the 16 samples were compiled in a spreadsheet and compared. Results: The PCR-SSP was more economical compared to other methods, and the serological method was faster than the molecular methods. However, all methods proved to be effective and safe in the detection of erythrocyte antigens. Conclusion: Analyzing the advantages and limitations of the molecular and serological methods tested in this study, we note that both are important and complementary. However, the choice of a methodology depends on the reality and needs of each health service. (C) 2019 Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.
引用
收藏
页码:44 / 49
页数:6
相关论文
共 24 条
  • [1] [Anonymous], APL BIOL MOL IM ER E
  • [2] Red cell genotyping and the future of pretransfusion testing
    Anstee, David J.
    [J]. BLOOD, 2009, 114 (02) : 248 - 256
  • [3] Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization
    Beiboer, SHW
    Wieringa-Jelsma, T
    Maaskant-Van Wijk, PA
    van der Schoot, CE
    van Zwieten, R
    Roos, D
    den Dunnen, JT
    de Haas, M
    [J]. TRANSFUSION, 2005, 45 (05) : 667 - 679
  • [4] Bordin José Orlando, 2007, Rev. Bras. Hematol. Hemoter., V29, P339, DOI 10.1590/S1516-84842007000400001
  • [5] Castilho I., 2008, REV BRAS HEMATOL HEM, V30, P259
  • [6] Castilho L, 2015, FUNDAMENTOS IMUNO HE
  • [7] Report of the First International Workshop on molecular blood group genotyping
    Daniels, G
    van der Schoot, CE
    Olsson, ML
    [J]. VOX SANGUINIS, 2005, 88 (02) : 136 - 142
  • [8] Franceschi DA, 2009, REV BRAS HEMATOL HEM, V31, P241
  • [9] Evolution of technology for molecular genotyping in blood group systems
    Gorakshakar, Ajit
    Gogri, Harita
    Ghosh, Kanjaksha
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 146 : 305 - 315
  • [10] Guelsin Gláucia Andréia Soares, 2011, Rev. Bras. Hematol. Hemoter., V33, P21, DOI 10.5581/1516-8484.20110009